Showing results (2031-2040 of 2,138) with videos related to
Sort By:
Pageof 214
Blood|June 17, 2022
TET2-mutant clonal hematopoiesis and risk of goutMridul Agrawal, Abhishek Niroula, Pierre Cunin, et al.Blood|July 27, 2010
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySusan P Whitman, Kati Maharry, Michael D Radmacher, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.Leukemia|July 24, 2015
Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG miceJ Etchin, J Montero, A Berezovskaya, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 14, 2011
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 yearsSamuel G Jacobson, Artur V Cideciyan, Ramakrishna Ratnakaram, et al.BMC Genomics|June 27, 2021
Exome-based investigation of the genetic basis of human pigmentary glaucomaCarly van der Heide, Wes Goar, Kacie J Meyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid LeukemiaChristopher J Walker, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.Medrxiv : the Preprint Server for Health Sciences|January 27, 2021
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation: A systematic review of study design and evidence strengthNoah A Haber, Emma Clarke-Deelder, Avi Feller, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Acute myeloid leukemia, version 2.2013Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.BMJ Open|January 12, 2022
Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strengthNoah A Haber, Emma Clarke-Deelder, Avi Feller, et al.Pageof 214